Funding for Neglected Diseases Increases to $2.5 Billion, But Big Killer Diseases Miss Out - Bill & Melinda Gates Foundation
Results of first ever global survey of public and private investment into R&D for neglected diseases
LONDON -- The first survey of global public and private investment into research and development (R&D) for new products for neglected diseases has found that funding was over $2.5 billion in 2007. The lion's share of funding—almost 80 percent—went towards HIV/AIDS, TB, and malaria. Many significant diseases responsible for killing millions of people in developing countries—including pneumonia and diarrheal diseases—remain underfunded, and collectively received less than 6 percent of total funding. These are the results of the G-FINDER 'Global Funding of Innovation for Neglected Disease' survey, released and published in London today by the George Institute for International Health.
To read the full press release, visit the George Institute web site.